Showing results (11-20 of 392) with videos related to
Sort By:
Pageof 40
Clinics in Laboratory Medicine|November 29, 2011
Genetics of chronic lymphocytic leukemiaAndrea Schnaiter, Daniel Mertens, Stephan StilgenbauerOncology Research and Treatment|February 19, 2016
Genomic Features: Impact on Pathogenesis and Treatment of Chronic Lymphocytic LeukemiaEugen Tausch, Daniel Mertens, Stephan StilgenbauerBest Practice & Research. Clinical Haematology|August 21, 2007
Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemiaThorsten Zenz, Hartmut Döhner, Stephan StilgenbauerFrontiers in Oncology|February 1, 2021
Telomere Dysfunction in Chronic Lymphocytic LeukemiaBilly Michael Chelliah Jebaraj, Stephan StilgenbauerOncology Research and Treatment|April 17, 2015
Obinutuzumab (GA101) for the treatment of chronic lymphocytic leukemia and other B-cell non-hodgkin's lymphomas: a glycoengineered type II CD20 antibodyValentin Goede, Christian Klein, Stephan StilgenbauerHematology. American Society of Hematology. Education Program|December 7, 2024
Risk-stratification in frontline CLL therapy: standard of careEugen Tausch, Christof Schneider, Stephan StilgenbauerF1000Prime Reports|August 29, 2014
Advances in treating chronic lymphocytic leukemiaEugen Tausch, Daniel Mertens, Stephan StilgenbauerExpert Opinion on Pharmacotherapy|November 22, 2011
Treating chronic lymphocytic leukemia with thalidomide and lenalidomideKrzysztof Giannopoulos, Daniel Mertens, Stephan StilgenbauerClinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Immunoglobulin heavy chain variable gene usage and (super)-antigen drive in chronic lymphocytic leukemiaAndreas Bühler, Thorsten Zenz, Stephan StilgenbauerBlood Cancer Discovery|December 12, 2025
Overcoming BTK Inhibitor Resistance in Chronic Lymphocytic Leukemia by Targeting PKCβBilly Michael Chelliah Jebaraj, Stephan StilgenbauerPageof 40